News

The transaction is subject to customary closing conditions and is expected to close by June 30, 2008. The commercialized products acquired consist of the QuickCat thrombus aspiration catheter,

To date, Ovation has used eCaseLink for five Phase I studies, and has seven Phase I studies underway or planned for 2008 and six Phase I studies planned

Most recently chief technology officer for Vyteris, Mr Hartounian previously served as a director and CEO of Protagenic Therapeutics, a biotechnology company he founded in 2006 to treat

Under the agreement, AngioDynamics has acquired Oncobionic for a total purchase price of $25.4 million, including approximately $400,000 of assumed liabilities. A deposit of $5 million was paid

Under the terms of the collaboration, Kai will receive an upfront cash payment of $25 million. Bristol-Myers Squibb will fund all future development, including the Phase IIb clinical

The company recently registered in the State of Florida to do business as ONI BioPharma. The company will refer to itself as Oni BioPharma from this point forward

This agreement with Embil, a multi-national dermatology company based in Turkey, is the company’s second entry into the $2.8 billion acne market. The territory includes Turkey, Azerbaijan, Kazakhstan,

The newly released data indicate that the Endeavor stent offers durable efficacy out to four years of follow-up, with no new events requiring target lesion revascularization (TLR) between

The IsoFlex Optim lead can be used with pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The small-diameter lead is built on the proven IsoFlex